Document is current
Any future updates will be listed below
-
Authors
Kardash, Elena
Petrova, Nataliya
Ganina, Ksenia
Tarasov, Sergey
Epstein, Oleg
-
Funding
Funding for this research was provided by:
OOO “NPF “MATERIA MEDICA HOLDING”, Russian Federation (N/A)
- License Information
-
More Information
Article History
Received: 18 October 2024
Accepted: 25 May 2025
First Online: 4 June 2025
Declarations
:
: All experiments were approved by the Porsolt’s ethics committee for animal experimentation (agreement E 53 1031).
: Not applicable.
: E. Kardash, N. Petrova, K. Ganina, S. Tarasov are employees of OOO “NPF “MATERIA MEDICA HOLDING” (fully or partly). O. Epstein is a founder of OOO “NPF “MATERIA MEDICA HOLDING”. OOO “NPF “MATERIA MEDICA HOLDING” sponsored the study, performed statistical analysis, made a decision to publish the work, and covered the current article processing charges, took part in the design of the experiments and the manuscript writing. The drug Prospekta is produced by OOO “NPF “MATERIA MEDICA HOLDING”. Patents on the technology used for Prospekta production belong to O. Epstein. The authors have disclosed those interests fully to journal of BMC Neuroscience.
